Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› USA
Clinical trial register · United States · industry-sponsored

Clinical Trials in the USA: Industry-Sponsored Studies

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9183 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 02 Nov 2026, 03:16 UTC
9183
Studies in scope
industry-sponsored, all four open statuses
4981
Recruiting now
open to new participants
2200
Lead sponsors
across recruiting studies
Top states
California 5323 Florida 4472 Illinois 2493 Georgia 2366 Arizona 2253
Narrow the register
Recruitment status
Phase
Lead sponsor
AstraZeneca294 Novartis Pharmaceuticals203 Eli Lilly and Company196 Merck Sharp & Dohme LLC184 AbbVie177
State
California5323 Florida4472 Illinois2493 Georgia2366 Arizona2253
All 51 states
Target enrolment
to

Trials in this register

9183 of 9183 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Not yet open
FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease
NCT00424866Peripheral Arterial Disease, Stenosis, Intermittent Claudication
Venturis Therapeutics, Inc.
Phase 1/2
24
Illinois
2028-10-15
Not yet open
T-MAXIMUM Pharmaceutical Inc
Phase 2
40
Texas
2027-12-30
Not yet open
Syntr Health Technologies, Inc.
Not applicable
180
California
2027-12-01
Not yet open
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
California, Colorado, District of Columbia, Florida, Georgia, Indiana, Massachusetts, Missouri
2027-11-23
Not yet open
Pulse Wave USA
Not applicable
60
Colorado
2027-09-25
Not yet open
Transdermal Delivery Solutions Corp
Phase 2/3
30
Florida
2027-09-02
Not yet open
Medically Supervised Ibogaine With 12-Month Digital Recovery Support for Opioid Use Disorder
NCT07871877Opioid Use Disorder, Opioid Withdrawal, Substance Use Disorders
DrugNaltrexone
Clive Michelsen
Phase 1/2
60
Colorado
2027-07-01
Not yet open
HemoSonics LLC
Observational
160
California, Georgia, Pennsylvania
2027-06-25
Not yet open
Jason Ahee, M.D.
Phase 2/3
60,000
Utah
2027-06-01
Not yet open
Aston Sci. Inc.
Phase 2
98
Washington
2027-06-01
Not yet open
Molecular Breast Imaging (MBI)-Guided Biopsy
NCT07114679Breast Cancer Detection, Breast Neoplasm, Molecular Imaging, Biopsy
Smart Breast Corp.
Not applicable
250
Texas
2027-06
Not yet open
Hypersound Treatment for Chronic Neuropathic and Radicular Pain
NCT07831447Chronic Neuropathic Pain, Radiculopathy, Sciatica, Peripheral Neuropathic Pain
Hypersound Medical Inc
Not applicable
71
Arizona
2027-06
Recruiting
Long-term Follow-up (LTFU) of Participants Who Received Azer-Cel
NCT07577583B-cell Mediated Autoimmune Disorders
TG Therapeutics, Inc.
Observational
32
North Carolina
2027-05-01
Not yet open
E-CEL UVEC Cell Injection Treatment of Perianal Fistulas
NCT07557134Cryptoglandular Perianal Fistula
Angiocrine Bioscience
Phase 2
78
New York
2027-05
Not yet open
Prizloncabtagene Autoleucel (Prizlon-cel) for the Treatment of Relapsed or Refractory Large B-cell Lymphoma Post FDA Approved CAR T-cell Therapy
NCT07875413Large B Cell Lymphoma, LBCL, Diffuse Large B Cell Lymphoma (DLBCL), Relapse Diffuse Large B Cell Lymphoma
DrugPrizloncabtagene Autoleucel
AbelZeta Inc.
Phase 2
55
Arizona, California
2027-05
Not yet open
argenx
Phase 2
170
Arizona, Texas
2027-04-01
Not yet open
Everfront Biotech Co., Ltd.
Phase 2/3
175
Rhode Island
2027-04-01
Not yet open
BioSignal Solutions LLC
Not applicable
30
California
2027-04
Not yet open
BioSensics
Observational
25
Massachusetts
2027-03-15
Not yet open
HemoSonics LLC
Observational
240
California, Georgia, Massachusetts
2027-03-15
Not yet open
Pivotal U.S. Clinical Validation of AI-COA® for Depression and Anxiety
NCT07279038Depression Disorders, Anxiety Disorders
Deliberate Solutions Inc.
Observational
650
Texas
2027-03-01
Not yet open
Phase 3 Bunionectomy Study
NCT07490496Postoperative Pain, Bunion
Cali Pharmaceuticals LLC
Phase 3
112
Utah
2027-03-01
Not yet open
NST-SPARK Open-Label Phase 1 STTR (IGNITE)
NCT07593456Schizophrenia / Schizoaffective Disorder
North Shore Therapeutics, Inc.
Not applicable
30
New York, Pennsylvania
2027-03-01
Not yet open
Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma
NCT06708455Malignant Melanoma With Metastasis, Malignant Melanoma, Malignant Melanoma Stage IIIc, Malignant Melanoma Stage IV
DrugRAPA
Rapa Therapeutics LLC
Phase 2
65
New Jersey
2027-03-01
Not yet open
C-CAR168, an Autologous Anti-CD20/BCMA Chimeric Antigen Receptor T-Cell Therapy, in Participants With Systemic Sclerosis (SSc) Refractory to Standard Therapy
NCT07854483Systemic Sclerosis (SSc), Systemic Sclerosis, Systemic Sclerosis (Scleroderma), Systemic Sclerosis - 2013 ACR/EULAR Classification Criteria
DrugC-CAR168
AbelZeta Inc.
Phase 1
12
Arizona
2027-03
Not yet open
Autonomous Healthcare, Inc.
Not applicable
10
North Carolina
2027-03
Recruiting
Nuvation Bio Inc.
Phase 2
40
California, Connecticut, Florida, Indiana, Louisiana, Massachusetts, New Jersey, New York
2027-03
Not yet open
(Z)-Endoxifen in Girls With MAS-Associated Peripheral Precocious Puberty
NCT07869732Precocious Puberty, Gonadotropin-dependent
Drug(Z)-endoxifen
Atossa Therapeutics, Inc.
Phase 2
6
Maryland
2027-03
Not yet open
Safety Study of XT-150 in Participants With ALS
NCT06704347Amyotrophic Lateral Sclerosis (ALS)
Xalud Therapeutics, Inc.
Phase 1
8
Arizona, Maryland, Massachusetts, Michigan
2027-03
Not yet open
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
92
Arizona, Colorado, Florida, Georgia, Illinois, Massachusetts, Michigan, Minnesota
2027-02-03
Not yet open
C-CAR168, an Autologous Anti-CD20/BCMA Chimeric Antigen Receptor T-Cell Therapy, in Participants With Progressive Multiple Sclerosis Refractory to Standard Therapy
NCT07825389Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progress Multiple Sclerosis (SPMS), Primary Progressive Multiple Sclerosis (PPMS)
DrugC-CAR168
AbelZeta Inc.
Phase 1/2
119
Arizona, California
2027-02
Not yet open
BioSensics
Observational
75
New York, Tennessee
2027-01-31
Not yet open
Conceptra Biosciences, LLC
Observational
180
California
2027-01-30
Not yet open
Nexalin Technology
Not applicable
160
Texas
2027-01-30
Not yet open
Biocoz Global Pte. Ltd.
Not applicable
10
California
2027-01-30
Not yet open
Sachi Bioworks Inc.
Phase 1
40
Arizona, Florida, Minnesota
2027-01-22
Not yet open
NeuroGT
Phase 1/2
9
Missouri
2027-01-18
Not yet open
Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies
NCT07240805Progressive Supranuclear Palsy(PSP), Dementia With Lewy Bodies (DLB), PSP, Lewy Body Dementia (LBD)
BioSensics
Observational
60
Maryland, Massachusetts
2027-01-15
Recruiting
Amgen
Observational
60
Colorado
2027-01-15
Not yet open
BioLite, Inc.
Phase 1/2
12
California
2027-01-15
Not yet open
Nob Hill Therapeutics, Inc.
Phase 1/2
100
Ohio
2027-01-11
Not yet open
MediWound Ltd
Phase 2
45
Florida
2027-01-10
Recruiting
Genentech, Inc.
Phase 2
321
California, North Carolina, Pennsylvania, Texas, Virginia
2027-01-08
Not yet open
Phase I Study of VLPDEN-02 Dengue Vaccine in Healthy Adults
NCT07831473Randomised Clinical Trial, Double Blind, Dengue, Challenge Test
VLP Therapeutics
Phase 1
42
Maryland
2027-01-04
Not yet open
NeuGATE Theranostics
Phase 1/2
52
Texas
2027-01-01
Not yet open
Aquilo Sports, LLC
Not applicable
40
Indiana
2027-01-01
Not yet open
Murata Vios, Inc.
Not applicable
35
Minnesota
2027-01-01
Not yet open
IntraAb, Inc.
Phase 1/2
60
California
2027-01-01
Not yet open
HomeCare Medication Management for People With Dementia
NCT07872072Dementia, Alzheimer's Disease and Related Dementias
HiDO Technologies
Not applicable
120
California
2027-01-01
Not yet open
A Study of Topical Duvelisib in Participants With Early-stage Mycosis Fungoides
NCT07714187Mycosis Fungoides, Cutaneous T-cell Lymphoma
DrugDuvelisib
SecuraBio
Phase 1
30
Maryland
2027-01
Not yet open
Bayer
Observational
50
West Virginia
2026-12-31
Not yet open
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 1
112
Connecticut, New Jersey, New York, Ohio, Texas, Washington
2026-12-31
Not yet open
Zopapogene Imadenovec for the Treatment of Recurrent Respiratory Papillomatosis in Children
NCT07901738Recurrent Respiratory Papillomatosis (RRP), Juvenile-onset Recurrent Respiratory Papillomatosis, Papillomavirus Infections
Precigen, Inc
Phase 3
15
District of Columbia
2026-12-31
Not yet open
Enzychem Lifesciences Corporation
Phase 2
60
New York, Rhode Island
2026-12-30
Recruiting
Innoviva Specialty Therapeutics
Phase 1
48
California, North Carolina, Texas
2026-12-30
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Alabama, Florida, Pennsylvania
2026-12-16
Not yet open
Bavarian Nordic
Phase 1
15
Kansas
2026-12-15
Not yet open
Wearable Sensor for Early Detection and Monitoring of Cognitive Decline
NCT07780162Mild Cognitive Impairment (MCI), Older Adults With Cognitive Decline, Older Adults
BioSensics
Observational
100
California
2026-12-15
Not yet open
BioSensics
Observational
25
Maryland, New York
2026-12-15
Not yet open
Boehringer Ingelheim
Phase 3
270
Arizona, California, Colorado, Kansas, Maryland, Massachusetts, Michigan, Minnesota
2026-12-14
Not yet open
Newleos Therapeutics, Inc.
Phase 2
30
Illinois
2026-12-01
Recruiting
NeuroRx, Inc.
Phase 2/3
240
Florida, Massachusetts
2026-12-01
Not yet open
XVIE to Treat Androgenetic Alopecia (AGA)
NCT07482423Androgenetic Alopecia
Restore Biologics Holdings, Inc. dba Xtressé
Phase 1/2
30
Florida, Maryland
2026-12-01
Recruiting
A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine
NCT07719608Resistant Migraine, Chronic Migraine Headache, Headache (Migraine), Headache, Cluster
Salvia BioElectronics
Not applicable
150
Georgia, Maryland, North Carolina
2026-12-01
Not yet open
iSCIB1+ in Combination With Ipilimumab and Nivolumab as First-Line Treatment for Advanced Unresectable Melanoma
NCT07815574Melanoma (Skin Cancer), Advanced Melanoma, Metastatic Melanoma, Skin Cancer
DrugsImmunoBody·Yervoy·Ipilimumab·Opdivo
Scancell Ltd
Phase 3
550
Colorado
2026-12-01
Not yet open
Caliway Biopharmaceuticals Co., Ltd.
Phase 3
300
California
2026-12
Not yet open
Eli Lilly and Company
Phase 3
3,000
Alabama, Arizona, California, Connecticut, Florida, Georgia, Hawaii, Illinois
2026-12
Not yet open
Nutromics
Observational
200
California, New York
2026-12
Recruiting
SPI-1005 in Adults Receiving Cochlear Implant
NCT06340633Hearing Loss, Cochlear Trauma
DrugEbselen
Sound Pharmaceuticals, Incorporated
Phase 2
40
Iowa, Ohio, Pennsylvania, South Carolina, Texas, Wisconsin
2026-12
Recruiting
Apellis Pharmaceuticals, Inc.
Phase 2/3
270
Illinois, New York
2026-12
Not yet open
Boston Scientific Corporation
Not applicable
74
Texas
2026-12
Not yet open
AFT Pharmaceuticals, Ltd.
Phase 3
1,366
Florida, Texas
2026-12
Not yet open
A Study of Vepugratinib (LY3866288) in Adults With Non-Muscle Invasive Bladder Cancer and Upper Tract Urothelial Cancer
NCT07827612Urinary Bladder Neoplasms, Urologic Neoplasms, Receptor, Fibroblast Growth Factor, Type 3
DrugVepugratinib
Eli Lilly and Company
Phase 2
161
South Carolina
2026-12
Recruiting
Anova Innovation Limited
Phase 1/2
84
California, Florida, Texas
2026-12
Not yet open
Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome
NCT07328529Aggressive Behavior in Fragile X Syndome
Azevan Pharmaceuticals
Phase 2
80
California, Illinois, Ohio
2026-12
Not yet open
Eli Lilly and Company
Phase 3
2,115
Arizona, California, Connecticut, Florida, Georgia, Hawaii, Illinois, Indiana
2026-12
Not yet open
Orum Therapeutics USA, Inc.
Phase 1
42
Michigan, Texas
2026-12
Recruiting
LTZ Therapeutics, Inc.
Phase 1
152
Arizona
2026-12
Not yet open
LAM-001 for the Treatment of Sarcoidosis Associated Pulmonary Hypertension (SAPH)
NCT07886554Sarcoidosis Associated Pulmonary Hypertension
DrugLAM-001
IRulya Therapeutics Inc.
Phase 2
60
Pennsylvania
2026-12
Not yet open
A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA
NCT07738822Immune Thrombocytopenia (ITP), Warm Autoimmune Hemolytic Anemia (WAIHA)
DrugVelinotamig specified on specified days
Cullinan Therapeutics Inc.
Phase 1/2
72
Texas
2026-12
Not yet open
N-803 in Combination With Pembrolizumab and Enfortumab Vedotin for Treatment of Urothelial Cancer
NCT07217496Metastatic Urothelial Carcinoma, Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma, Urothelial Cancer
DrugsEnfortumab Vedotin·Keytruda·Pembrolizumab
ImmunityBio, Inc.
Phase 1
18
California
2026-12
Not yet open
Bristol-Myers Squibb
Phase 2
80
California, Florida, Illinois, Massachusetts, Oregon, Pennsylvania, Tennessee, Texas
2026-11-30
Recruiting
Jazz Pharmaceuticals
Phase 2
50
California, Florida, Georgia, Kentucky, South Carolina
2026-11-30
Not yet open
AbbVie
Phase 3
520
Arizona, California, Colorado, District of Columbia, Florida, Georgia, Illinois, Massachusetts
2026-11-30
By invitation
Efficacy of an LED Mask
NCT07890233Fine Lines and Wrinkles, Skin Health, Skin Tone
Therabody, Inc.
Not applicable
110
New York
2026-11-30
Not yet open
The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma
NCT07386002Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
T-MAXIMUM Pharmaceutical Inc
Phase 2
40
Maryland
2026-11-30
Not yet open
Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEA
NCT07780968Esophageal Cancer, GastroEsophageal Cancer, Gastroesophageal-junction Cancer, HER2-positive Gastric Cancer
DrugZanidatamab
Jazz Pharmaceuticals
Observational
300
California, Texas
2026-11-30
Recruiting
Hoffmann-La Roche
Phase 3
1,600
California, Florida, New York, Virginia
2026-11-30
Not yet open
Jazz Pharmaceuticals
Phase 4
40
California, Louisiana, North Carolina
2026-11-18
Recruiting
Hoffmann-La Roche
Phase 3
350
Tennessee
2026-11-15
Recruiting
Cognixion
Not applicable
30
California
2026-11-15
Not yet open
AFT Pharmaceuticals, Ltd.
Phase 2
30
Texas
2026-11-13
Not yet open
PharmaMar
Phase 1/2
231
Nebraska, Texas
2026-11-12
Not yet open
Boehringer Ingelheim
Phase 3
350
Florida, Georgia
2026-11-07
Recruiting
argenx
Phase 2
120
California, Florida, Michigan, Texas, Utah, Virginia
2026-11-05
Not yet open
Bristol-Myers Squibb
Phase 1
50
Utah
2026-11-03
Not yet open
Boehringer Ingelheim
Phase 3
600
Arizona, California, Florida, Kansas, Massachusetts, New Mexico, North Carolina, South Carolina
2026-11-02
Not yet open
Jubaan Ltd.
Not applicable
120
Florida
2026-11-02
Not yet open
Usability and Clinical Validation of the Flu A/B/COVID-19 + RSV Multiplex Rapid Test
NCT07875270SARS-CoV-2 Infection, Influenza A, Influenza B, RSV
CorDx, Inc.
Not applicable
1,500
Georgia
2026-11-01
Not yet open
Talk Parenting Education Program II
NCT07462052Parenting Practices, Self Efficacy, Stress, Child Behavior
Oregon Research Behavioral Intervention Strategies, Inc.
Not applicable
184
Oregon
2026-11-01
Recruiting
TG Therapeutics, Inc.
Phase 2
120
Colorado, Florida, Michigan, North Carolina, South Carolina
2026-11-01
Not yet open
Natural History to Assess Disease in Patients With MPS IIIC
NCT07712003Sanfilippo Syndrome Type C, Mucopolysaccharidosis (MPS) IIIC
Phoenix Nest
Observational
35
Texas
2026-11-01
Not yet open
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 1
8
Nebraska
2026-11-01
Not yet open
The Precision Mito- Mito Map COMPASS Study
NCT07856121Mitochondrial Diseases, Myalgic Encephalomyelitis Chronic Fatigue Syndrome, Post-COVID-19 Condition, Postural Orthostatic Tachycardia Syndrome
AI Agent Vault, Inc. d/b/a Precision Mito
Observational
400
Florida
2026-11-01
Not yet open
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum
NCT07569367Frontotemporal Lobar Degeneration (FTLD), Frontotemporal Dementia (FTD), Corticobasal Degeneration, Corticobasal Syndrome (CBS)
BioSensics
Observational
60
Maryland, Massachusetts
2026-11-01
Recruiting
General Neuro Inc.
Not applicable
60
Massachusetts
2026-11-01
Not yet open
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
48
Texas
2026-11-01
Not yet open
A Study of LY3873862 in Participants With Sporadic or Familial Amyotrophic Lateral Sclerosis (ALS).
NCT07883590Amyotrophic Lateral Sclerosis, Cytochrome P-450 Enzyme System
Eli Lilly and Company
Phase 1
32
California, Colorado, Kansas
2026-11
Recruiting
Aerin Medical
Not applicable
30
Delaware
2026-11
Not yet open
Gilead Sciences
Phase 2
80
California, New Jersey
2026-11
Not yet open
Otto Bock Healthcare Products GmbH
Not applicable
100
Illinois
2026-11
Not yet open
Mercy BioAnalytics, Inc.
Not applicable
1,750
Massachusetts, Texas
2026-11
By invitation
Spine Registration Using 3D-Scanning
NCT06267248Spine Surgery
Advanced Scanners Inc.
Observational
10
Massachusetts
2026-11
Not yet open
IKS04 Regimen in Advanced Solid Tumors That Express CA242
NCT07738939Colorectal Cancer, Gastro Esophageal Junctional Cancer, Gastric Cancer (GC), GEJ Adenocarcinoma
Iksuda Therapeutics Ltd.
Phase 1
120
California, Massachusetts, Tennessee, Texas
2026-11
Recruiting
A Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid Tumors
NCT07887971NSCLC, NSCLC (Advanced Non-small Cell Lung Cancer), ES-SCLC, Small Cell Lung Cancer Extensive Stage
Aktis Oncology, Inc.
Phase 1
152
Florida
2026-11
Not yet open
HeartFlow, Inc.
Not applicable
500
New York
2026-11
Not yet open
Sperm, Exposure and Endocrine Disruptors
NCT07703046Fertility, Male Fertility, Sperm Count, Low, Sperm Quality
Million Marker Wellness, Inc.
Not applicable
100
California
2026-11
Not yet open
GV101 for Friedreich's Ataxia (FA) Treatment
NCT07870590Friedreich's Ataxia
Graviton Bioscience Corporation
Phase 2
48
New Jersey
2026-11
Not yet open
Oral Care Program for Mouth Side Effects During Head and Neck Radiation Therapy
NCT07885033Head and Neck Cancer (H&N), Oral Mucositis (Ulcerative) Due to Radiation, Stomatitis (Oral Mucositis), Xerostomia Due to Radiotherapy
UNCANCER LLC
Not applicable
50
Florida
2026-11
Not yet open
Eli Lilly and Company
Phase 3
1,000
Arizona, California, Colorado, Florida, Georgia, Hawaii, Indiana, Louisiana
2026-11
Not yet open
Eli Lilly and Company
Phase 2
460
Arizona, California, Connecticut, Florida, Idaho, Illinois, Iowa, Kansas
2026-11
Not yet open
AskBio Inc
Phase 2
18
Ohio, Pennsylvania, South Carolina
2026-11
Not yet open
dōTERRA International
Not applicable
40
Utah
2026-11
Recruiting
Boston Scientific Corporation
Not applicable
66
California, Florida, Massachusetts, New York, Ohio, Pennsylvania, Washington, West Virginia
2026-11
Not yet open
Kore Fiber PLF Study
NCT07868510Degenerative Lumbar Spine Diseases, Lumbar Degenerative Disc Disease, Lumbar Spinal Stenosis, Spondylolisthesis
Kolosis Bio, LLC
Not applicable
75
Ohio
2026-11
Not yet open
Microbio Co Ltd
Observational
1,500
Indiana, Maryland, New Mexico, Tennessee, Texas
2026-11
Recruiting
Corneal Trauma Diagnostic Study
NCT07887425Ocular Trauma
InnSight Technology, Inc.
Not applicable
40
Pennsylvania
2026-11
Not yet open
Modified SOLTIVE Study
NCT07838077Calculi, Renal, Calculi, Urinary, Benign Prostatic Hyperplasia
Olympus Corporation of the Americas
Observational
250
Kansas
2026-11
Not yet open
CooperVision International Limited (CVIL)
Not applicable
35
Indiana
2026-11
Recruiting
Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD
NCT07224763ESRD (End-Stage Renal Disease), Kidney Transplantation, Xenotransplantation
United Therapeutics
Phase 1/2
50
New York
2026-11
Recruiting
Lungpacer Medical Inc.
Not applicable
120
California
2026-10-31
Not yet open
International Health Strategies LLC
Not applicable
400
Pennsylvania
2026-10-31
Not yet open
Amgen
Phase 2
15
Florida, North Carolina, Pennsylvania
2026-10-31
Not yet open
Hoffmann-La Roche
Phase 2
450
New York
2026-10-31
Not yet open
EASEE® System Pivotal Study for the United States of America
NCT07301346Drug-Resistant Focal Epilepsy
Precisis US, Inc.
Not applicable
200
New York
2026-10-31
Recruiting
Biogen
Phase 3
42
Texas
2026-10-31
Not yet open
Boehringer Ingelheim
Phase 3
600
Alabama, California, Florida, Louisiana, Maryland, North Carolina, Utah
2026-10-31
Recruiting
Sarepta Therapeutics, Inc.
Phase 4
20
Texas
2026-10-30
Not yet open
Smith & Nephew, Inc.
Not applicable
330
Colorado, Georgia, Indiana
2026-10-30
Not yet open
Smith & Nephew, Inc.
Not applicable
25
Minnesota
2026-10-30
Recruiting
Hoffmann-La Roche
Phase 2
40
District of Columbia, Georgia, Nebraska, New York, West Virginia
2026-10-30
Recruiting
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
NCT07473700Hypertension, Pulmonary, Lung Diseases, Interstitial
Tectonic Operating Company, Inc.
Phase 2
25
Arizona, California, Idaho, Michigan
2026-10-30
Not yet open
Hofseth Biocare ASA
Not applicable
150
California
2026-10-30
Recruiting
Agomab Spain S.L.U.
Phase 2
320
Arizona, Florida, New York, Rhode Island, Texas
2026-10-30
Not yet open
Biosense Webster, Inc.
Not applicable
2,300
Texas
2026-10-30
Not yet open
Pathalys Pharma
Phase 3
56
New York
2026-10-30
Not yet open
A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
NCT07873931Systemic Lupus Erythematosus, Sjögren's Disease, Rheumatoid Arthritis, Idiopathic Inflammatory Myopathies
Bristol-Myers Squibb
Phase 1
60
California, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New York, Pennsylvania
2026-10-30
Recruiting
Solenic Medical, Inc.
Not applicable
165
Ohio, Oklahoma
2026-10-30
Not yet open
Bristol-Myers Squibb
Phase 2
200
Arizona, Arkansas, California, Florida, Georgia, Maryland, Massachusetts, New York
2026-10-30
Recruiting
TerSera Therapeutics LLC
Phase 1
176
Arkansas, District of Columbia, Florida, Georgia, Illinois, Iowa, Louisiana, Michigan
2026-10-30
Not yet open
Eisai Inc.
Observational
270
New Jersey
2026-10-30
Recruiting
A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.
NCT07903415Pancreatic Ductal Adenocarcinoma, Esophageal Cancer, Carcinoma, Non-Small-Cell Lung (NSCLC), Gastric Carcinoma
Pfizer
Phase 1
280
Michigan, Texas
2026-10-29
Not yet open
Radicle Science
Not applicable
330
California
2026-10-29
By invitation
TruVascular Access - Ultrasound-Guided Vascular Access Study
NCT07798427Peripheral Venous Catheterization, Difficult Intravenous Access, Catheterization, Peripheral
Truway Health, Inc.
Not applicable
250
New York
2026-10-29
Recruiting
TMZ + RT + 5-ALA + LIDU SDT System for Newly Diagnosed Butterfly Glioma
NCT07862647Glioblastom WHO Grade 4, GBM, bGBM, Butterfly GBM
DrugGliolan
Alpheus Medical, Inc.
Phase 1
30
New York
2026-10-29
Not yet open
Clinical Nutrition Research Center, Illinois Institute of Technology
Not applicable
64
Illinois
2026-10-28
Not yet open
Amgen
Phase 3
230
Florida
2026-10-28
Not yet open
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
NCT07707895Small Cell Lung Cancer, Large Cell Neuroendocrine Lung Carcinoma, Extrapulmonary Neuroendocrine Carcinoma of Small Cell Histology, Extrapulmonary Neuroendocrine Carcinoma of Large Cell Histology
DrugsZL-1310·Obrixtamig·Atezolizumab
Boehringer Ingelheim
Phase 1/2
60
District of Columbia, Florida, Kentucky
2026-10-28
Not yet open
Merck Sharp & Dohme LLC
Phase 2
480
New Jersey, Ohio, Oregon
2026-10-27
Not yet open
T3D Therapeutics, Inc.
Phase 2/3
376
North Carolina
2026-10-26
Recruiting
Boehringer Ingelheim
Phase 1
90
Florida, Georgia, Pennsylvania, Tennessee, Texas
2026-10-26
Recruiting
Larimar Therapeutics, Inc.
Phase 3
150
Florida, Illinois, New Jersey, Texas
2026-10-26
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Alabama, Arizona, California, Connecticut, Florida, Georgia, Idaho, Illinois
2026-10-26
Recruiting
Biogen
Observational
10
North Carolina
2026-10-26
Not yet open
Evaluation of F&P Mask, US, 2026
NCT07847814Chronic Respiratory Conditions, Obstructive Sleep Apnea (OSA)
Fisher and Paykel Healthcare
Not applicable
45
South Carolina
2026-10-26
Not yet open
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ATI-105 in Healthy Adults
NCT07869654Friedreich Ataxia, Cardiomyopathies, Central Nervous System Diseases, Neuromuscular Diseases
Adjuvia Therapeutics, Inc.
Phase 1
60
Florida
2026-10-26
Not yet open
Alembic Therapeutics
Phase 2
100
Michigan
2026-10-24
Recruiting
Schweitzer Engineering Laboratories
Observational
330
Idaho, Washington
2026-10-23
Not yet open
Pfizer
Phase 1
80
Illinois, Texas
2026-10-23
By invitation
Intracardiac Echocardiography Catheter Supply-Chain Reliability and Clinical Access Study
NCT07788040Cardiovascular Diseases, Arrhythmias, Cardiac, Atrial Fibrillation
Truway Health, Inc.
Observational
200
New York
2026-10-23
Not yet open
Care COMPASS Study
NCT07904793Diabetes Mellitus ( Type 1 and Type 2), Hypertension
Fitbit LLC
Not applicable
200
Oregon
2026-10-22
Not yet open
Abbott Point of Care
Observational
425
New Jersey, Pennsylvania, Wisconsin
2026-10-22
Recruiting
Retropsoas Technologies, LLC
Observational
120
Florida, Missouri, Pennsylvania, Texas
2026-10-22
Recruiting
Tornier Perform™ Reversed Monopost Study
NCT07764614Non-inflammatory Degenerative Joint Disease, Rhematoid Arthritis, Correction of Functional Deformity, Fracture of the Humeral Head
Stryker Trauma and Extremities
Observational
150
California, Ohio
2026-10-22
Recruiting
35Pharma Inc., a GSK company
Phase 1/2
126
Missouri, South Carolina, Texas
2026-10-21
Recruiting
Ecotera Health LLC
Observational
15
Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware
2026-10-21
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
380
Virginia
2026-10-21
Not yet open
Clinical Nutrition Research Center, Illinois Institute of Technology
Not applicable
10
Illinois
2026-10-20
Not yet open
MTX-531-001 Phase 1 Study in Advanced Solid Tumors
NCT07874880Solid Tumors (Phase 1), HNSCC, Endometrial Cancer, Her2-negative Metastatic Breast Cancer
MEKanistic Therapeutics, Inc.
Phase 1
71
California
2026-10-20
Not yet open
Pfizer
Phase 3
258
Florida, Texas
2026-10-19
Recruiting
Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
NCT07807345Head & Neck Squamous Cell Carcinoma, Non-Small Cell Lung Cancer, Esophageal Cancer, Gastric Cancer
DrugPembrolizumab
Sutro Biopharma, Inc.
Phase 1
285
Florida, Massachusetts, Oklahoma, Texas, Virginia
2026-10-19
Not yet open
Summit Therapeutics
Phase 2
100
California
2026-10-19
Recruiting
Focused Ultrasound for Behavioral Health
NCT07851038Depression, Anxiety, Obsessive Compulsive Disorder (OCD)
Attune Neurosciences Inc
Not applicable
300
California
2026-10-19
Not yet open
Pfizer
Phase 1
144
California
2026-10-16
Recruiting
Absorption, Distribution, Metabolism, and Excretion of 14C-VX-407 After a Single Oral Dose
NCT07868926Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Vertex Pharmaceuticals Incorporated
Phase 1
8
Nebraska
2026-10-16
Recruiting
Novo Nordisk A/S
Phase 3
84
Iowa, Louisiana, Minnesota, Missouri, North Carolina, Oklahoma, Pennsylvania, Texas
2026-10-16
Not yet open
EMD Serono Research & Development Institute, Inc.
Phase 3
404
Massachusetts
2026-10-15
Not yet open
Phase 2a Study to Assess Safety and Efficacy of Two 177Lu-TLX250 Dosing Regimens in Advanced Relapsed or Recurrent ccRCC
NCT07870746ccRCC, Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC), Renal Cell Cancer Metastatic
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 2
40
California, Florida, Michigan, Ohio, Pennsylvania, Wisconsin
2026-10-15
Not yet open
Takeda
Phase 2
36
California, Florida, Maryland, Missouri, New Jersey, New York, Ohio, Texas
2026-10-15
Not yet open
PHASE 1 TRIAL OF Lm-LLO-TT AND GEMCITABINE IN UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
NCT07828236Pancreas Cancer, Duct Cell Adenocarcinoma, Pancreatic Cancer, Advanced Pancreatic Adenocarcinoma
Loki Therapeutics, Inc.
Phase 1
18
New York
2026-10-15
Not yet open
The CLASP III TR CED Study
NCT07859709Tricuspid Regurgitation, Heart Valve Diseases, Heart Diseases, Cardiovascular Diseases
Edwards Lifesciences
Observational
2,350
California
2026-10-15
Not yet open
AGED Diagnostics Clinical Validation Study
NCT07867574MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease), Fibrosis and Cirrhosis of Liver, MetALD
Active Genomes Expressed Diagnostics, Corp
Observational
500
Maryland
2026-10-15
Recruiting
Urmila DIwekar
Phase 1/2
100
Florida
2026-10-15
Not yet open
Adraxe Corp.
Early Phase 1
15
Minnesota
2026-10-15
Recruiting
Philips Clinical & Medical Affairs Global
Observational
85
Colorado
2026-10-15
Recruiting
Novartis Pharmaceuticals
Phase 1
30
Ohio
2026-10-15
Not yet open
Cullinan Therapeutics Inc.
Phase 1
90
California, Florida, Georgia, New York, Texas
2026-10-15
Not yet open
Hemorai Inc
Not applicable
80
Massachusetts
2026-10-15
Recruiting
The restor3d Outcomes Registry
NCT07563803Joint Replacement, Arthropathy
Restor3D
Observational
2,250
North Carolina
2026-10-15
Recruiting
Voice-based Outcome Identification and Clinical Evaluation in Heart Failure
NCT07870395Heart Failure, Chronic Heart Failure, Chronic Heart Disease
Noah Labs
Observational
450
Massachusetts
2026-10-15
Recruiting
Novartis Pharmaceuticals
Phase 2
220
Tennessee, Texas
2026-10-14
Recruiting
LigaChem Biosciences, Inc.
Phase 1/2
191
Massachusetts, New York, South Carolina, Texas
2026-10-14
Recruiting
Pfizer
Phase 3
600
Florida, Minnesota, Nevada, New York, Ohio, Oregon, Tennessee, Texas
2026-10-14
Recruiting
Amgen
Phase 3
180
Arkansas, California, Florida, Indiana, Texas
2026-10-13
Recruiting
Ambros Therapeutics, Inc.
Phase 3
135
Arizona
2026-10-13
Recruiting
A Study of DS-3939a in Participants With Solid Tumors
NCT07739966Solid Tumor, Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
DrugsDS-1103a·DS-3939a·Pemetrexed·Carboplatin
Daiichi Sankyo
Phase 1/2
400
Arkansas, California, Florida, Oregon, Rhode Island, Texas, Virginia
2026-10-13
Recruiting
Medtronic Cardiac Rhythm and Heart Failure
Not applicable
110
Minnesota
2026-10-13
Recruiting
Ascletis Pharma (China) Co., Limited
Phase 1
86
Florida
2026-10-13
Recruiting
Merck Sharp & Dohme LLC
Phase 2
15
Iowa
2026-10-13
Recruiting
GI Innovation, Inc.
Phase 1/2
107
New York
2026-10-12
Recruiting
IgG Binding Protein LT in Support of a Healthy Gut on the Go
NCT07873957Gut Health, Gastrointestinal Symptoms, Safety in Healthy Adults
Bactolife A/S
Not applicable
800
California
2026-10-12
Active, closed
Pfizer
Observational
1
New York
2026-10-12
Not yet open
Perioperative Photobiomodulation in Facial Plastic Surgery
NCT07846631Postoperative Facial Ecchymosis, Postoperative Facial Edema
Elixir MD Inc
Not applicable
40
Texas
2026-10-12
Recruiting
Safety and Tolerability Evaluation of IgG Binding Protein LT
NCT07824011Safety and Tolerability in Healthy Volunteers
Bactolife A/S
Not applicable
40
California
2026-10-12
Not yet open
Reckitt Benckiser Healthcare (UK) Limited
Observational
600
Illinois
2026-10-11
Active, closed
Kingdom
Not applicable
16
New York
2026-10-11
Not yet open
Cerus Corporation
Phase 2
25
Colorado
2026-10-10
Recruiting
Kardium Inc.
Observational
500
Arkansas, Washington
2026-10-09
Not yet open
SalivIQ Diagnostics, Inc.
Observational
668
Louisiana, Massachusetts, Texas
2026-10-09
Recruiting
ModernaTX, Inc.
Phase 4
300
Kansas, Kentucky, North Carolina, Tennessee, Texas
2026-10-09
Not yet open
Lumos Pharma
Phase 1
30
Georgia
2026-10-08
Not yet open
Radicle Science
Not applicable
550
California
2026-10-08
Recruiting
Cambiotics ApS
Not applicable
70
Illinois
2026-10-08
Recruiting
Novo Nordisk A/S
Phase 1
60
California, Maryland
2026-10-08
Not yet open
Unilever R&D
Not applicable
50
Minnesota
2026-10-08
Recruiting
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
1,120
Florida, New York
2026-10-08
Recruiting
Applied Biologics, LLC
Phase 3
253
Ohio
2026-10-08
Recruiting
A Study of MGC030 in Participants With Advanced Solid Tumors
NCT07822399Urothelial Cancer, GastroEsophageal Cancer, Colorectal Cancer, Esophageal Cancer
MacroGenics
Phase 1
314
New York
2026-10-07
Recruiting
ModernaTX, Inc.
Phase 1
96
California, Colorado, Minnesota, Ohio, Texas, Virginia
2026-10-07
Recruiting
Madrigal Pharmaceuticals, Inc.
Phase 4
150
Arizona, Arkansas, California, Florida, Louisiana, North Carolina, Ohio, Tennessee
2026-10-07
Recruiting
Novartis Pharmaceuticals
Phase 3
180
Florida, Georgia, Massachusetts, Michigan, Ohio, Texas
2026-10-07
Recruiting
Merck Sharp & Dohme LLC
Phase 2
200
Texas
2026-10-07
Recruiting
Biogen
Phase 1/2
69
Missouri, Texas
2026-10-07
Recruiting
Genmab
Phase 3
600
California, Georgia, Washington
2026-10-07
Recruiting
Astellas Pharma Global Development, Inc.
Phase 1/2
156
Massachusetts
2026-10-07
Recruiting
AbbVie
Phase 2
300
Arizona
2026-10-07
Not yet open
Sanofi
Observational
100
Indiana
2026-10-07
Recruiting
Merck Sharp & Dohme LLC
Phase 3
646
California, Florida, Texas
2026-10-07
Recruiting
Regeneron Pharmaceuticals
Phase 4
754
New Jersey
2026-10-06
Recruiting
Bristol-Myers Squibb
Phase 1/2
84
California, Colorado, Florida, New York, Oregon, Pennsylvania, Texas
2026-10-06
Recruiting
Hoffmann-La Roche
Phase 3
400
California, Georgia, Michigan, Nevada, New Mexico
2026-10-06
Recruiting
Hoffmann-La Roche
Phase 1
180
Illinois, Missouri, Nebraska, Texas, Wisconsin
2026-10-06
Not yet open
Celgene
Phase 1
24
California
2026-10-06
Recruiting
AiCuris Anti-infective Cures AG
Phase 2
24
Alabama, Florida, Georgia, Maryland, New Jersey, North Carolina, Ohio
2026-10-05
Recruiting
Medtronic MiniMed, Inc.
Not applicable
1,500
California, Colorado, Connecticut, Florida, Georgia, Idaho, Texas, Virginia
2026-10-05
Recruiting
Driving Time and Facial Skin Hydration Asymmetry in Florida Drivers
NCT07764809Skin Diseases, Photoaging, Skin Hydration
IAS Skin Care
Observational
80
Florida
2026-10-05
Recruiting
Kymera Therapeutics, Inc.
Phase 1
54
Nebraska
2026-10-05
Active, closed
Han Xu, M.D., Ph.D., FAPCR, Medical Director, IRB Chair
Phase 2/3
600
Maryland
2026-10-05
Recruiting
Perception Dynamics Institute
Not applicable
90
California
2026-10-05
Recruiting
Novo Nordisk A/S
Phase 1
60
California, Maryland
2026-10-05
Active, closed
Han Xu, M.D., Ph.D., FAPCR, Medical Director, IRB Chair
Early Phase 1
20
Maryland
2026-10-05
Recruiting
Murata Vios, Inc.
Not applicable
30
Minnesota
2026-10-03
Recruiting
AbbVie
Phase 1
60
Illinois
2026-10-02
Recruiting
Abiomed Inc.
Not applicable
250
Florida, Indiana, Minnesota, Missouri, New Jersey, New York, North Carolina, Pennsylvania
2026-10-02
Recruiting
TriGemX Bio, Inc.
Phase 3
1,500
Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Idaho
2026-10-02
Recruiting
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma
NCT07741877Sarcoma, Soft Tissue Sarcoma (STS), Advanced Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma (UPS)
DrugLifileucel
Iovance Biotherapeutics, Inc.
Phase 2
80
Florida, New York
2026-10-02
Not yet open
Bristol-Myers Squibb
Phase 3
176
Arizona, California, Connecticut, Florida, Georgia, Illinois, Massachusetts, Missouri
2026-10-02
Recruiting
Gilead Sciences
Phase 2
125
Florida, Texas
2026-10-01
Not yet open
NANOVAE to Treat Knee Osteoarthritis (KOA)
NCT06606561Knee Osteoarthritis
Nova Vita Laboratory
Phase 1/2
24
Missouri
2026-10-01
Recruiting
kTMP-Enhanced Motor Rehabilitation for Chronic Stroke Recovery (KULMINATE) Pilot
NCT07631078Stroke, Chronic Stroke Patients, Arm Weakness as a Consequence of Stroke
Magnetic Tides
Not applicable
6
California
2026-10-01
Not yet open
Comprehensive Enhanced Care Management Under CalAIM for High-Risk Medi-Cal Members
NCT07587073Complex Care, Post-Acute Care Utilization, Housing Instability, Residential Care Transition
StratiHealth
Not applicable
1,200
California
2026-10-01
Recruiting
Pluvicto Real-world Investigation in Survival in Metastatic CRPC
NCT07697989Prostatic Neoplasms, Castration-Resistant, Neoplasm Metastasis
Novartis Pharmaceuticals
Observational
1,085
New Jersey
2026-10-01
Recruiting
Boehringer Ingelheim
Phase 1/2
55
Florida, Massachusetts, New Jersey, New York, Tennessee
2026-10-01
Recruiting
Sanofi
Phase 4
660
California, Florida, Georgia, Illinois, Iowa, Kansas, Louisiana, Maryland
2026-10-01
Not yet open
3-C Institute for Social Development
Not applicable
66
North Carolina
2026-10-01
Recruiting
TMV Vaccine Alone or With Toripalimab-tpzi for Recurrent Head and Neck Squamous Cell Carcinoma
NCT07898124Squamous Cell Carcinoma of Head and Neck, Squamous Cell Carcinoma of Head and Neck (SCCHN), HNSCC, Neoplasm Recurrence, Local
DrugsJS001·Toripalimab
Metaclipse Therapeutics Corporation
Phase 1
30
Texas
2026-10-01
Not yet open
SMSbiotech
Phase 1/2
125
Florida
2026-10-01
Recruiting
Amgen
Phase 3
159
California, Florida
2026-10-01
Not yet open
The ReCAna for Lower ExtremIty Venous OBstructions and In-StEnt Restenosis Registry
NCT07529756Chronic Venous Disease, Chronic Venous Insufficiency, CVI, Venous Thrombosis, Thrombosis (Stent Thrombosis)
Intervene, Inc.
Observational
500
Oklahoma
2026-10-01
Not yet open
Clinical Evaluation of an Alarm Activated Detection System to Enable Early Intervention of Emerging Respiratory Decline With the Linshom Medical Continuous Predictive Respiratory Sensor (CPRS)
NCT07793981Post Surgical Respiratory Failure, Respiratory Complication, Opioid Induced Respiratory Depression, Respiratory Arrest
Linshom Medical, Inc.
Not applicable
394
Maryland, Ohio
2026-10-01
Not yet open
A Mobile Text Approach to Measurement and Feedback for Wraparound Care Coordination
NCT07300930Mental Health Services, Mobile Technologies, Technology Development
3-C Institute for Social Development
Not applicable
216
North Carolina
2026-10-01
Recruiting
SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET
NCT07873450Solid Tumor, NSCLC, Colorectal Cancer, Head and Neck Cancer
Full-Life Technologies UK Limited
Phase 1/2
208
Minnesota
2026-10-01
Recruiting
Gilead Sciences
Phase 2
132
Colorado, Florida, Georgia, Tennessee
2026-10-01
Recruiting
GlaxoSmithKline
Phase 3
3,000
Arizona, California, Florida, Idaho, Indiana, Kansas, New York, South Carolina
2026-10-01
Recruiting
Arrowhead Pharmaceuticals
Phase 3
10
Missouri
2026-10
Not yet open
Aruna Bio, Inc.
Phase 1
20
Texas
2026-10
Not yet open
AFT Pharmaceuticals, Ltd.
Phase 3
180
Florida
2026-10
Not yet open
A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular Disease
NCT07839936Atherosclerosis, Cardiovascular Disease, Hypercholesterolemia
DrugVERVE-102
Verve Therapeutics, Inc.
Phase 2
175
Texas
2026-10
Not yet open
Newish Biotech (Wuxi) Co., Ltd.
Phase 1/2
78
New York
2026-10
Not yet open
Cochlear
Not applicable
200
Colorado
2026-10
Not yet open
Safety and Efficacy Study of GEB-101 Injection in Subjects With TGFBI-related Corneal Dystrophy
NCT07750678Hereditary Corneal Dystrophy, Corneal Abnormality, Corneal Dystrophies, Corneal Dystrophies, Hereditary
GenEditBio Limited
Phase 1/2
30
California
2026-10
Not yet open
Eli Lilly and Company
Phase 1
16
Wisconsin
2026-10
Recruiting
First-in-human Study of UX016 in GNEM
NCT07511556GNE Myopathy
Ultragenyx Pharmaceutical Inc
Phase 1/2
24
California, New Jersey
2026-10
Recruiting
FT839 in Autoimmune Diseases
NCT07800871ANCA-Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM), Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE)
Fate Therapeutics
Phase 1/2
446
California
2026-10
Not yet open
Conversational AI for Adult Flu Vaccination Decisions
NCT07896850Influenza, Human, Vaccine Hesitancy
Calypta Systems, Inc.
Not applicable
220
California
2026-10
Not yet open
Safety and Systemic Exposure of YCANTH (VP-102) in Subjects With Common Warts (Verruca Vulgaris) (COVE-5)
NCT07881952Common Warts, Common Warts (Verruca Vulgaris), Human Papilloma Virus (HPV), Warts
Verrica Pharmaceuticals Inc.
Phase 2
30
Kentucky, New York
2026-10
Recruiting
Study of ORJ-001 for the Treatment of IPF
NCT07869147Idiopathic Pulmonary Fibrosis
Oorja Bio, Inc.
Phase 2
95
Florida, Pennsylvania
2026-10
Not yet open
UltraTrac Clinical Pilot Study
NCT07864714Hemodynamic Monitoring
AcQumen Medical, Inc.
Observational
50
District of Columbia
2026-10
Not yet open
Ablative Solutions, Inc.
Phase 3
202
Tennessee
2026-10
Not yet open
Eli Lilly and Company
Phase 1
617
California, Florida, Georgia, New Jersey, Ohio, Texas
2026-10
Not yet open
Callahan-Young LLC DBA Jigsawdio
Not applicable
80
North Carolina, Texas
2026-10
Recruiting
PRG Science & Technology Co., Ltd.
Phase 2
5
Michigan
2026-10
Not yet open
RYZ711 Diagnostic Platform Study
NCT07862582Prostate Cancer (Adenocarcinoma), Adenocarcinoma of the Prostate, Metastatic Castration-resistant Prostate Cancer (mCRPC), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
RayzeBio, Inc.
Phase 1/2
116
Nebraska
2026-10
Not yet open
vTv Therapeutics
Phase 2
40
Georgia
2026-10
Recruiting
Nacuity Pharmaceuticals, Inc.
Phase 3
80
Texas
2026-10
Not yet open
ProGo Menopause Wellbeing Study
NCT07611305Menopause Related Conditions
Hofseth Biocare ASA
Not applicable
100
California
2026-10
Not yet open
A Clinical Trial to Evaluate the Effects of A Supplement on Symptoms of Menopause and Overall Well-being
NCT07903480Menopause, Menopausal Symptoms, Hot Flashes, Night Sweats
Primal Harvest, LLC
Not applicable
40
Nevada
2026-10
Recruiting
A Study of Cebranopadol for Opioid Withdrawal Symptoms in Adults With Chronic Pain
NCT07874620Chronic Pain, Pain, Opioid Withdrawal (Disorder), Opioid Use Disorder
DrugCebranopadol
Adneuris Therapeutics, Inc.
Phase 2
45
Ohio, Texas
2026-10
Not yet open
Caliway Biopharmaceuticals Co., Ltd.
Phase 3
320
California, Florida, Georgia, Maryland, Nebraska, New York, Ohio, Tennessee
2026-10
Recruiting
Ray Therapeutics, Inc.
Phase 2/3
60
Arizona, California, Florida, Hawaii, Illinois, Michigan, Minnesota, New Jersey
2026-10
Recruiting
Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction
NCT07729137Corneal Edema, Fuchs, Fuchs Dystrophy, Fuchs' Endothelial Dystrophy
Emmecell
Phase 2
121
California, Florida, Georgia, Illinois, Indiana, Kansas, Minnesota, Missouri
2026-10
Recruiting
Faron Pharmaceuticals Ltd
Phase 2
90
California, Colorado, Connecticut, Florida, Massachusetts, North Carolina, Tennessee, Texas
2026-10
Recruiting
Vivance Group
Not applicable
45
Nevada
2026-10
Recruiting
Dignify Therapeutics
Phase 1
40
Texas
2026-10
By invitation
PepsiCo Global R&D
Observational
50
Florida
2026-10
Recruiting
Eight Sleep Inc.
Not applicable
100
Massachusetts
2026-10
Not yet open
Gilead Sciences
Phase 1/2
100
California, New Jersey, New York, Utah
2026-10
Recruiting
Study of Afimetoran in Adults With Cutaneous Lupus Erythematosus
NCT07881120Cutaneous Lupus Erythematosus (CLE), Systematic Lupus Erythematosus
DrugAfimetoran
Beeline Medicines Corporation
Phase 2/3
390
California, Florida, Montana
2026-10
By invitation
Blood Donation Study for ALPCO Syphilis-T and Syphilis-NT Assay Development
NCT07830550Healthy Volunteers, Syphilis Serologic Assay Development, Blood Specimen Collection, Diagnostic Assay Development
American Laboratory Products Company
Observational
50
New Hampshire
2026-10
Recruiting
Vogenx, Inc.
Phase 2
36
California, Colorado, Florida, Georgia, North Carolina, Pennsylvania, Tennessee, Texas
2026-10
Recruiting
Sagimet Biosciences Inc.
Phase 3
800
Arkansas, California, Florida, Illinois, Indiana, Michigan, New Hampshire, North Carolina
2026-10
Recruiting
Alkermes, Inc.
Phase 2
180
Florida
2026-10
Not yet open
Vibrant Medical Ltd.
Observational
10
Florida
2026-10
Not yet open
P+F Products + Features USA Inc.
Not applicable
780
Alabama, Arizona, California, District of Columbia, Florida, Illinois, Indiana, Kansas
2026-10
Not yet open
A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)
NCT07843459Healthy Volunteers, Alzheimer Disease, Amyloid, Plaque, Amyloid
Eli Lilly and Company
Phase 1
111
California, Florida, Georgia, Michigan
2026-10
Recruiting
Apreo Health, Inc.
Early Phase 1
15
Alabama, Kansas
2026-10
Not yet open
RENEW: Study of Porcine Liver Support in Participants With Acute-on-Chronic Liver Failure
NCT07429838Acute on Chronic Liver Failure (ACLF), Hepatic Encephalopathy (HE)
eGenesis, INC
Phase 1/2
20
Missouri, Wisconsin
2026-10
Recruiting
Opus Genetics, Inc
Phase 1/2
10
Arizona, Pennsylvania, Texas
2026-10
Recruiting
GE Healthcare
Phase 2/3
175
Michigan
2026-10
Not yet open
Aleniglipron Hepatic Impairment Study
NCT07872033Hepatic Impairment
DrugAleniglipron
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Phase 1
36
Florida, Texas
2026-10
Recruiting
Qualia Life Sciences
Not applicable
50
California
2026-10
Not yet open
SURGE Therapeutics
Phase 3
400
Minnesota, New York, North Carolina
2026-10
Recruiting
Kedrion S.p.A.
Phase 3
161
Connecticut, Florida, New Hampshire, Texas
2026-10
By invitation
Hydration, Ergonomic Risk, and Fatigue Across Multiple PepsiCo Facilities
NCT07848256Hydration Status and Ergonomic Risk in Frontline Workers
PepsiCo Global R&D
Observational
60
Florida
2026-10
Not yet open
BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease
NCT07729995Rheumatoid Arthritis (RA), Systemic Lupus Erthematosus (SLE), Dermatomyositis (DM), Systemic Sclerosis (SSc)
DrugLMY-922
Luminary Therapeutics
Phase 1
94
Massachusetts
2026-10
Recruiting
A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
NCT07840326Primary Progressive Multiple Sclerosis, Primary Progressive MS, Primary Progressive Multiple Sclerosis (PPMS), Secondary Progressive MS (SPMS)
Sundance Biosciences, Inc.
Phase 2
20
Florida, Georgia, New York, North Carolina, Ohio, Oklahoma, Texas
2026-10
Recruiting
Haya Therapeutics, Inc.
Phase 1
10
Massachusetts, Missouri, Ohio
2026-10
Not yet open
Eli Lilly and Company
Phase 2
50
Alabama, California, Florida, Massachusetts, New Jersey, Texas, Virginia, Wisconsin
2026-10
Recruiting
ALPFA Medical
Not applicable
250
Tennessee
2026-10
Not yet open
Natera, Inc.
Not applicable
1,010
Alabama, California, Florida, Illinois, Minnesota, New York, North Carolina, Ohio
2026-10
Recruiting
A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.
NCT07559175Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF), Pancreatic Enzyme Abnormality, Pancreatic Diseases
DrugZenpep
Aimmune Nestlé Health Science US R&D, LLC
Phase 2
66
Arizona, Arkansas, California, Florida, Kansas, Maryland, Montana, Ohio
2026-10
Not yet open
HeartFlow, Inc.
Not applicable
350
North Carolina
2026-10
Not yet open
Trellis Bioscience LLC
Phase 1
14
Nebraska
2026-10
Recruiting
An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM)
NCT07426419Dilated Cardiomyopathy (DCM), BAG3 Mutation Associated Dilated Cardiomyopathy
Affinia Therapeutics
Phase 1/2
22
Florida, Missouri, New York, Texas
2026-10
Not yet open
Validation of cueStim for Reduction of Freezing of Gait in Parkinson's Disease
NCT07675408Parkinson's Disease With Freezing of Gait
Fortis Medical Devices Limited
Not applicable
60
Florida, Georgia, Kansas, Oregon, Washington
2026-10
Not yet open
Real Time Craniotomy Planning Using Mixed Reality
NCT07468370Neurosurgery, Surgical Planning, Brain Tumor Adult, Craniotomy Tumor Removal Surgery
Brainlab AG
Observational
54
Massachusetts
2026-10
Recruiting
Pfizer
Phase 3
1,100
Pennsylvania, Texas
2026-09-30
Recruiting
Hoffmann-La Roche
Phase 3
3,900
Alabama, Florida, Tennessee
2026-09-30
Recruiting
Biomed Industries, Inc.
Phase 3
210
Arizona, California, Colorado, Florida, Illinois, Maryland, Massachusetts, New York
2026-09-30
Recruiting
RAI Services Company
Not applicable
480
Florida, Georgia, Illinois, New Jersey, Texas
2026-09-30
Recruiting
Hoffmann-La Roche
Phase 3
2,500
Alabama, California, Florida
2026-09-30
Recruiting
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
NCT07520006B-cell Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
DrugsBexobrutideg·Obinutuzumab·Venetoclax·Rituximab
Nurix Therapeutics, Inc.
Phase 1/2
150
Colorado, Florida, Oregon, Pennsylvania, Tennessee, Texas
2026-09-30
Recruiting
Hoffmann-La Roche
Phase 3
600
California, Virginia
2026-09-30
Recruiting
Post-market Safety Study of LUMISIGHT
NCT07572162Hypersensitivity Reactions
Lumicell, Inc.
Observational
1,500
Alabama, California
2026-09-30
Recruiting
Trevi Therapeutics
Phase 3
201
Delaware, Florida, North Carolina, Texas
2026-09-30
Not yet open
Scienceforbrain, UAB
Not applicable
304
Illinois
2026-09-30
Recruiting
Alcon Research
Phase 3
230
California, Kansas, Kentucky, Massachusetts, North Carolina, Pennsylvania, Tennessee, Texas
2026-09-30
Recruiting
Lumicell, Inc.
Observational
1,500
Alabama, California
2026-09-30
Not yet open
Annexon, Inc.
Phase 3
605
Florida, Maryland, Massachusetts, North Carolina, Oregon
2026-09-30
Recruiting
Pfizer
Phase 3
660
Alabama, California, Florida, Kentucky, Michigan, Mississippi, Missouri, Montana
2026-09-30
Recruiting
Fortvita Biologics (USA)Inc.
Phase 1/2
360
Arizona, California, Georgia, New York, Texas
2026-09-30
By invitation
OrthoFundamentals, LLC
Observational
200
Idaho
2026-09-30
Recruiting
Ionis Pharmaceuticals, Inc.
Phase 3
30
North Carolina
2026-09-30
Recruiting
Solstice Oncology, Inc.
Phase 2
100
California, Florida, Illinois, Maryland, Massachusetts, New York, Ohio, Tennessee
2026-09-30
Recruiting
Lantheus Medical Imaging
Phase 2/3
408
Michigan
2026-09-30
Recruiting
Multitude Therapeutics Inc.
Phase 2/3
512
Florida, Texas
2026-09-30
Recruiting
Deep Sleep in Older Adults
NCT07316153Insomnia, Insomnia Chronic
Proactive Life Inc
Phase 2
180
New York
2026-09-30
Recruiting
A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic Wound Infections
NCT07379684Surgical Wound Infection, Traumatic Wound Infection
Macro Biologics, Inc.
Phase 1
44
California, Idaho, Maryland, Missouri, Ohio
2026-09-30
Recruiting
Novartis Pharmaceuticals
Phase 2
259
Alabama, California, Florida, Georgia, Indiana, Kansas, Louisiana, Michigan
2026-09-29
Recruiting
Phrontline Biopharma
Phase 1/2
150
California, Florida, New York, Pennsylvania, Tennessee, Texas, Virginia
2026-09-29
Not yet open
A Study of IBI3042 in Healthy Adult Participants
NCT07842393Healthy Volunteers (HV)
Fortvita Biologics (USA)Inc.
Phase 1
32
Kansas
2026-09-29
Recruiting
Corbus Pharmaceuticals Inc.
Phase 3
260
Alabama, Arizona, California, Colorado, Connecticut, Delaware, Florida, Illinois
2026-09-29
Recruiting
Biojiva LLC
Phase 1/2
152
Arizona, Mississippi, Nevada, Ohio, Texas, Utah, Washington
2026-09-29
Not yet open
Shionogi
Phase 1
30
Florida
2026-09-29
Recruiting
Charm Therapeutics
Phase 1
40
California, Connecticut, Michigan
2026-09-28
Not yet open
Pfizer
Phase 3
920
Ohio
2026-09-28
Recruiting
GlaxoSmithKline
Phase 3
218
California, Oklahoma
2026-09-28
Recruiting
A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT07441278Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
DrugNS-863
NS Pharma, Inc.
Phase 2
177
Tennessee
2026-09-28
By invitation
Head Diagnostics
Observational
120
Georgia, Massachusetts
2026-09-28
Not yet open
Hikma Pharmaceuticals USA Inc.
Phase 2
44
New Jersey, Utah
2026-09-28
Recruiting
Evaluation of the F&P Mask, US, 2026
NCT07826429Chronic Respiratory Conditions, Obstructive Sleep Apnea (OSA)
Fisher and Paykel Healthcare
Not applicable
45
Missouri
2026-09-28
Recruiting
NervGen Pharma
Phase 3
150
Alabama, Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Georgia
2026-09-28
Recruiting
A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC
NCT07725796Bladder (Urothelial, Transitional Cell) Cancer, NMIBC, Urothelial Carcinoma Bladder, Urothelial Carcinoma in Situ
UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd.
Phase 1
30
Arizona, California, Colorado, Florida, Massachusetts, Michigan, Nebraska, New York
2026-09-28
Recruiting
Ascletis Pharma (China) Co., Limited
Phase 1
144
Texas, Utah
2026-09-28
Recruiting
Amneal Pharmaceuticals, LLC
Phase 3
190
California, Florida, Nebraska, New York, Rhode Island, South Carolina, Texas
2026-09-28
Recruiting
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 3
84
Florida
2026-09-28
Not yet open
AcQumen Medical, Inc.
Observational
400
Connecticut
2026-09-27
Recruiting
Alcon Research
Phase 3
178
Illinois, North Carolina, Tennessee, Virginia
2026-09-27
Recruiting
DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau
NCT07142278Alzheimer Disease, Alzheimer Disease (AD), Preclinical Alzheimer's Disease
Nuravax, Inc.
Phase 1
24
Florida
2026-09-25
Not yet open
Merck Sharp & Dohme LLC
Phase 1
16
Florida
2026-09-25
Recruiting
Eli Lilly and Company
Phase 3
150
Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana
2026-09-25
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,104
Connecticut, Florida, Indiana, Iowa, Maryland, New York, North Carolina, South Carolina
2026-09-25
Recruiting
Cytogel Pharma, LLC
Phase 1/2
32
Utah
2026-09-25
Recruiting
HALEON
Not applicable
360
Florida
2026-09-25
Recruiting
Acurx Pharmaceuticals Inc.
Phase 2
20
California, Connecticut, Florida, Georgia, Idaho, Illinois, Massachusetts, Michigan
2026-09-25
Recruiting
BeOne Medicines
Phase 1
24
Texas
2026-09-25
Recruiting
Phathom Pharmaceuticals, Inc.
Phase 3
500
Ohio
2026-09-25
By invitation
Forecasting Relapse Outcomes With AlloHeme-based Risk Detection in Post-Allo-HCT AML/MDS Patients (FORWARD)
NCT07607327AML (Acute Myelogenous Leukemia), MDS (Myelodysplastic Syndrome), CMML
CareDx
Observational
400
California, Missouri
2026-09-24
Recruiting
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
NCT07816666Platinum-sensitive Relapsed Epithelial Ovarian Cancer, Platinum-sensitive Relapsed Fallopian Tube Cancer, Platinum-sensitive Relapsed Primary Peritoneal Cancer
DrugsTorvutatug samrotecan·Bevacizumab
AstraZeneca
Phase 3
600
Alaska, Florida, Indiana, Louisiana, Maryland, Michigan, New York, Ohio
2026-09-24
Recruiting
Akeso
Phase 3
900
Arizona, California, Colorado, Connecticut, Massachusetts, Michigan, New York, Oregon
2026-09-24
Recruiting
Treatment of Chronic Thyroid Eye Disease With MHB018A
NCT07622121Thyroid Eye Disease, TED
DrugMHB018A
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 3
135
Florida
2026-09-24
Recruiting
HMPL-A830 in Solid Tumors
NCT07718581Solid Tumor, Adult
Hutchmed
Phase 1/2
147
California, Florida, New Jersey, Tennessee, Utah
2026-09-24
Recruiting
AstraZeneca
Phase 3
750
Arizona, California, Colorado, Florida, Georgia, Illinois, Kentucky, Massachusetts
2026-09-24
Recruiting
Agios Pharmaceuticals, Inc.
Phase 3
54
Georgia, New York, Pennsylvania, Texas
2026-09-24
Recruiting
UNITY DX Cornea Study
NCT07768735Tomography
Alcon Research
Observational
110
Utah
2026-09-24
Recruiting
Knee Cartilage Repair Registry
NCT07786207Knee Injuries, Joint Surface Knee Lesions
Smith & Nephew, Inc.
Observational
1,000
Colorado, District of Columbia, Indiana, Kentucky, Oklahoma, Pennsylvania
2026-09-23
By invitation
The BANYAN Trial, an ALS MyMatch Trial Evaluating Safety, Biomarker Activity, and Microglial Activation of Nasal Foralumab
NCT07688239ALS (Amyotrophic Lateral Sclerosis), ALS - Amyotrophic Lateral Sclerosis, ALS
DrugForalumab Nasal
Tiziana Life Sciences LTD
Phase 2
44
Florida, Illinois, Massachusetts, Minnesota
2026-09-23
Recruiting
Tomey Corporation
Observational
30
Florida
2026-09-23
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 1
16
Arizona
2026-09-23
By invitation
Study to Evaluate Xtressé Gummy Supplement in Men With Androgenic Alopecia
NCT07637071Androgenic Alopecia, Hair Loss/Baldness, Hair Thinning
Restore Biologics Holdings, Inc. dba Xtressé
Not applicable
48
Florida
2026-09-23
Recruiting
Vertanical GmbH
Phase 3
810
Alabama, Arizona, California, Florida, Kansas, North Carolina, Ohio, Oklahoma
2026-09-22
Recruiting
AbbVie
Phase 3
940
Indiana
2026-09-22
Recruiting
Adneuris Therapeutics, Inc.
Phase 3
160
Arizona, California, Colorado, Georgia, Illinois, Maryland, New Jersey, Oklahoma
2026-09-22
Not yet open
Flutemetamol F 18 Injection Formulation Comparison
NCT07873463Cognitive Dysfunction
GE Healthcare
Phase 2
20
Florida, Georgia
2026-09-22
Active, closed
JOURNEY LVAD: JOURNEY Left Ventricular Assist Device
NCT07363473Aortic Valve Regurgitation, Aortic Valve Disease Mixed, Aortic Insufficiency
JC Medical, Inc., an affiliate of Edwards Lifesciences LLC
Not applicable
50
Massachusetts, Tennessee
2026-09-22
Recruiting
TRIFORMIS RESILIA Real-world Study Assessing Safety and Performance (TRIBLAZE Study)
NCT07684313Heart Valve Diseases, Heart Diseases, Cardiovascular Diseases, Tricuspid Valve Disease
Edwards Lifesciences
Observational
75
Indiana
2026-09-22
Recruiting
Eli Lilly and Company
Phase 1
184
Florida, Texas
2026-09-22
Recruiting
Novo Nordisk A/S
Phase 3
650
California, District of Columbia, Florida, Georgia, Illinois, Indiana, Louisiana, Missouri
2026-09-22
Recruiting
Amgen
Phase 1
308
Florida
2026-09-22
Recruiting
Sanofi
Phase 1
16
Florida
2026-09-22
Recruiting
WiQo S.p.A.
Not applicable
30
Kansas, Oklahoma
2026-09-21
Recruiting
Evaluation of Diagnostic Accuracy and Clinical Performance of the UllCORE Bloodstream Infection (BSI) Test
NCT07859852Blood Stream Infection, Blood Stream Infections, Sepsis, Fungemia
Deepull Diagnostics S.L.
Observational
1,500
California, Florida, Maryland, Massachusetts, Michigan, Missouri, Ohio, Pennsylvania
2026-09-21
Recruiting
Pelage Pharmaceuticals, Inc.
Phase 2/3
600
Alabama, Arkansas, California, Florida, Georgia, Idaho, Indiana, Kentucky
2026-09-21
Recruiting
Daily Nouri
Not applicable
160
California
2026-09-19
Recruiting
AdaptDx, Inc.
Observational
16
Washington
2026-09-18
Active, closed
Incyte Corporation
Phase 1
10
Nebraska
2026-09-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
802
District of Columbia, Massachusetts, Oregon, Texas
2026-09-18
Recruiting
Novartis Pharmaceuticals
Phase 2
180
Alabama, California, Florida, Kansas, Maryland, Texas, Virginia
2026-09-18
Recruiting
Daiichi Sankyo
Phase 3
200
Maryland, Nevada, Tennessee, Texas
2026-09-18
Not yet open
Mynerva Inc.
Not applicable
100
Mississippi
2026-09-18
Recruiting
NeuroOne Medical Technologies Corporation
Observational
100
Florida, New Jersey
2026-09-18
Recruiting
The Effects of Quercefit® and Ubiqsome™ in Mitigating Inflammation and Promoting Metabolic Health
NCT07760506Healthy Aging, Inflammaging, Metabolic Health, Quercetin
Applied Science & Performance Institute
Not applicable
60
Florida
2026-09-18
Recruiting
4D Molecular Therapeutics
Phase 3
514
Arizona, California, Colorado, Connecticut, Florida, Illinois, Indiana, Maryland
2026-09-18
Recruiting
BioLab Holdings
Not applicable
160
Oklahoma
2026-09-18
Recruiting
Elite AF IDE Trial (Elite AF)
NCT07287436Atrial Fibrillation (AF), Stroke
Boston Scientific Corporation
Not applicable
400
Arkansas, North Carolina
2026-09-18
Not yet open
GlaxoSmithKline
Phase 1
25
California, Louisiana, Maryland, Missouri
2026-09-18
Recruiting
Jazz Pharmaceuticals
Phase 2/3
260
Arizona, California, Connecticut, Florida, Georgia, Hawaii, Idaho, Illinois
2026-09-18
Recruiting
Daiichi Sankyo
Phase 1/2
220
California, Colorado, Connecticut, Massachusetts, New York, Oregon, Tennessee, Texas
2026-09-17
By invitation
Vertex Pharmaceuticals Incorporated
Phase 3
605
Colorado, Florida, Idaho, Texas
2026-09-17
Recruiting
CRPS-RISE Outcomes Registry
NCT07811362Complex Regional Pain Syndrome I (CRPS I)
Ambros Therapeutics, Inc.
Observational
270
North Carolina
2026-09-17
Recruiting
Corvus Pharmaceuticals, Inc.
Phase 1
25
Indiana, Kentucky, Massachusetts, New York, North Dakota, Ohio, Pennsylvania, Tennessee
2026-09-17
Not yet open
Radicle Science
Not applicable
220
California
2026-09-17
Not yet open
Radicle Science
Not applicable
550
California
2026-09-17
Recruiting
Boehringer Ingelheim
Phase 3
466
Alabama, California, Connecticut, Florida, Indiana, Kansas, Michigan, Minnesota
2026-09-17
Recruiting
Pfizer
Phase 3
258
Alabama, California, Florida, Minnesota, Texas
2026-09-17
Recruiting
Novo Nordisk A/S
Phase 1
148
Utah
2026-09-17
Recruiting
Janssen Research & Development, LLC
Phase 2
100
Louisiana, Massachusetts, New York, Tennessee
2026-09-16
Recruiting
Novo Nordisk A/S
Phase 3
210
Arizona, California, Connecticut, Florida, Hawaii, Illinois, Iowa, Kansas
2026-09-16
By invitation
Sanofi
Phase 3
1,508
California, Florida
2026-09-16
Recruiting
Amphista Therapeutics Ltd
Phase 1
54
Virginia
2026-09-16
Recruiting
AstraZeneca
Phase 3
950
Florida, Maryland, Montana, Ohio
2026-09-16
Recruiting
UCB Biopharma SRL
Phase 3
100
Ohio
2026-09-16
Recruiting
YolTech Therapeutics Co., Ltd
Phase 2
36
Alabama, Colorado, Missouri, Pennsylvania
2026-09-16
Not yet open
Bristol-Myers Squibb
Phase 1
6
Wisconsin
2026-09-16
Recruiting
ViiV Healthcare
Phase 1
112
California, Maryland
2026-09-15
Recruiting
AstraZeneca
Phase 3
1,330
Arkansas, California, Florida, Hawaii, Illinois, Iowa, Maryland, Michigan
2026-09-15
Not yet open
Primus Pharmaceuticals
Phase 4
20
Ohio
2026-09-15
Recruiting
CSL Behring
Phase 3
63
California, Colorado, Florida, Indiana, Maryland, New Jersey, New York, North Carolina
2026-09-15
Recruiting
GE Healthcare
Observational
60
California
2026-09-15
Recruiting
Transverse Tibial Bone Transport (TTT) in the Management of Chronic Diabetic Lower Extremity Wounds
NCT07444593Diabetic Foot Ulcer, Chronic Ulcers of the Lower Limb
Biodynamik, Inc
Not applicable
100
Florida
2026-09-15
Recruiting
Eli Lilly and Company
Phase 1
34
Florida, Texas
2026-09-15
By invitation
Cryo-FIRST: Effectiveness of INTERCEPT Fibrinogen Complex (IFC) for Trauma-Associated Hemorrhage
NCT07218185Hypofibrinogenemia, Hemorrhage, Trauma Associated Hemorrhage, Hemorrhagic Shock
Cerus Corporation
Observational
320
Colorado, Florida, Maryland, Missouri
2026-09-15
Recruiting
AdaptDx, Inc.
Observational
24
California
2026-09-15
Not yet open
Enamel Lesion Detection With New DX Tool
NCT07819370Enamel Lesions, Caries
DrugToothpaste
Colgate Palmolive
Phase 4
5
Georgia
2026-09-15
Recruiting
Meiji Co., Ltd.
Not applicable
118
Illinois
2026-09-14
Recruiting
ATR 1072 in Participants With PRKAG2 Syndrome
NCT07738107Cardiac Glycogenosis, Cardiomyopathy, Hypertrophic, Wolff-Parkinson-White Syndrome
Atrium Therapeutics
Phase 1/2
37
Missouri
2026-09-14
By invitation
RNS System for Drug-Resistant Focal Epilepsy in Adolescents: A Real-World Study
NCT07823465Focal Epilepsy, Drug-resistant Focal Epilepsy
NeuroPace
Observational
100
Massachusetts
2026-09-14
Recruiting
General Mills
Not applicable
184
Minnesota
2026-09-14
Recruiting
Observational, Non-interventional Biomarker and Endotyping Study
NCT07675265ARDS (Acute Respiratory Distress Syndrome)
Prenosis, Inc.
Observational
1,200
Illinois
2026-09-14
Recruiting
Good Molecules, LLC
Phase 4
60
North Carolina
2026-09-14
Recruiting
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors
NCT07807956Advanced Solid Tumors, Non-Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma
AbbVie
Phase 1
130
Michigan, North Carolina, Texas
2026-09-14
Recruiting
Good Molecules, LLC
Phase 4
24
New York
2026-09-14
Recruiting
Shionogi
Phase 3
2,000
Florida, Ohio
2026-09-14
Recruiting
IBA Proton Therapy, Inc.
Not applicable
10
Pennsylvania
2026-09-14
Active, closed
Qualia Life Sciences
Not applicable
100
California
2026-09-12
Recruiting
A Study in Adults With Geographic Atrophy
NCT07606365Geographic Atrophy
DrugSTL303
Sitala Bio LTD
Phase 2
300
California, Colorado, Connecticut, Illinois, Maryland, Massachusetts, New York, Pennsylvania
2026-09-11
Recruiting
Vividion Therapeutics, Inc.
Phase 2
140
Arizona, Michigan, West Virginia
2026-09-11
Recruiting
Eli Lilly and Company
Phase 1
18
Florida
2026-09-11
Recruiting
Medtronic Cardiovascular
Not applicable
1,186
Alabama, Arizona, California, Connecticut, Georgia, Illinois, Minnesota, New York
2026-09-11
Not yet open
A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism
NCT07284745Irritability Associated With Autism Spectrum Disorder
DrugsKarX-EC·KarXT
Bristol-Myers Squibb
Phase 3
176
Alabama, Arizona, California, Colorado, Florida, Georgia, Illinois, Kentucky
2026-09-11
Recruiting
Clinical Outcomes of 3D Printed and Milled Complete Dentures
NCT07586774Edentulous Mouth, Edentulous Jaw
Dentsply Sirona Implants and Consumables
Not applicable
68
North Carolina
2026-09-11
Active, closed
AI Mental Health Tool vs. Psychoeducation Control
NCT07841483Depressive Disorder, Depressive Symptoms
Slingshot AI
Not applicable
500
New York
2026-09-11
Recruiting
A Study of AWT020 in Participants With Advanced Solid Tumors
NCT07822919Advanced Cancers (Solid Tumors)
DrugAWT020
Anwita Biosciences
Phase 1
96
Florida, Virginia
2026-09-11
Recruiting
GlaxoSmithKline
Phase 3
624
Florida, South Dakota, Utah
2026-09-11
Recruiting
Johnson & Johnson Vision Care, Inc.
Not applicable
150
Florida, Georgia, Missouri, New York, Rhode Island, Tennessee, Texas, Virginia
2026-09-10
Recruiting
Bristol-Myers Squibb
Phase 2
160
District of Columbia, Georgia, Kentucky, Maryland, Mississippi, Nebraska, New York, Ohio
2026-09-10
Recruiting
Takeda
Phase 3
324
Arizona, California, District of Columbia, Florida, Georgia, Massachusetts, Missouri, Montana
2026-09-10
Recruiting
AstraZeneca
Phase 3
200
Arizona, California, Florida, Georgia, Indiana, Louisiana, Maryland, North Carolina
2026-09-10
Not yet open
NinaMED Pty Ltd
Phase 3
290
New Jersey
2026-09-10
Recruiting
Lyv Life Inc. (dba: Cora)
Not applicable
120
Florida
2026-09-10
Recruiting
Summit Therapeutics
Phase 2/3
800
Arizona, California, District of Columbia, Florida, Minnesota, Tennessee, Washington
2026-09-10
Recruiting
Johnson & Johnson Vision Care, Inc.
Not applicable
150
Florida, Illinois, New York, Ohio, Tennessee, Texas, Virginia
2026-09-10
Recruiting
Merck Sharp & Dohme LLC
Phase 1
400
Florida, Maryland, Missouri, New Jersey, Ohio, Texas
2026-09-10
Recruiting
Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC
NCT07813637Prostate Cancer, Castration-Resistant Prostate Cancer (CRPC), Metastatic Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer Patients
DrugJANX007
Janux Therapeutics
Phase 1
110
Tennessee
2026-09-10
Recruiting
Eli Lilly and Company
Phase 1
179
California, Florida, Georgia, Michigan
2026-09-09
Recruiting
Pfizer
Phase 3
600
Arizona, California, Connecticut, District of Columbia, Idaho, Indiana, New Jersey, Ohio
2026-09-09
Recruiting
Dentsply Sirona Implants and Consumables
Not applicable
130
New York
2026-09-09
Recruiting
GlaxoSmithKline
Phase 1/2
184
California, North Carolina, Ohio
2026-09-09
Recruiting
Clinical Evaluation of a Multi-functional Beauty Device on Cosmetic Skin Outcomes
NCT07871708Skin Appearance, Skin Texture, Skin Sagging, Wrinkles
APR Co., Ltd.
Not applicable
50
Maryland
2026-09-09
Recruiting
A Clinical Trial to Evaluate the Effects of Adrenal Adapt on Sleep Quality, Daytime Energy, Stress Resilience, and Cognitive Performance.
NCT07893561Improves Daytime Energy Levels, Reduces Afternoon Energy Crashes and Midday Fatigue, Improves Overall Sleep Quality and Restorative Sleep, Helps People Fall Asleep Faster and Wake Less During the Night
Bioligent
Not applicable
40
Nevada
2026-09-09
Recruiting
Triveni Bio
Phase 2
90
California, Florida, Indiana, Michigan, Ohio, Pennsylvania, South Carolina, Texas
2026-09-09
Recruiting
Device for Treating Generalized Anxiety
NCT07819773Generalized Anxiety Disorder (GAD)
BTL Industries Ltd.
Not applicable
40
Colorado, Illinois, Indiana
2026-09-09
Recruiting
Hoffmann-La Roche
Phase 1
60
Florida
2026-09-09
Recruiting
JCR Pharmaceuticals Co., Ltd.
Phase 1/2
12
California, Pennsylvania, Virginia
2026-09-09
Recruiting
Pfizer
Phase 3
4,670
Alabama, California, Connecticut, Florida, Georgia, Hawaii, Illinois, Iowa
2026-09-08
Recruiting
Biogen
Phase 3
90
California, Virginia
2026-09-08
Recruiting
Bristol-Myers Squibb
Phase 3
850
California, Colorado, Florida, Illinois, Maryland, Minnesota, Missouri, Nebraska
2026-09-08
Recruiting
Incyte Corporation
Phase 3
426
Alabama, Arizona, California, Colorado, District of Columbia, Florida, Georgia, Illinois
2026-09-08
Recruiting
Vyriad, Inc.
Phase 1
40
Minnesota
2026-09-08
Recruiting
Regeneron Pharmaceuticals
Phase 1
36
Georgia, New Jersey, Oregon
2026-09-08
Rows per page Showing 1–500 of 9183
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site. Derived from ClinicalTrials.gov. Retrieved 2 November 2026. https://priyalifescience.com/clinical-trials-usa

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,183 studies in total at the last sync on 02 Nov 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in the US?

4,981 of the 9,183 studies in this register are recruiting new participants as of the 02 Nov 2026, 03:16 UTC sync. A further 499 have not yet opened recruitment, 3,328 are active but closed to new participants, and 375 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 9,183 studies
PhaseStudiesRecruitingShare
Phase 31,99795921.7%
Not applicable1,51378416.5%
Phase 21,43474515.6%
Phase 11,41490915.4%
Observational1,38871315.1%
Phase 1/298862110.8%
Phase 2/32301252.5%
Phase 41851082%
Early Phase 134170.4%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
AstraZeneca294143
Novartis Pharmaceuticals20399
Eli Lilly and Company196107
Merck Sharp & Dohme LLC184104
AbbVie17785
Pfizer17097
Janssen Research & Development, LLC14665
Hoffmann-La Roche14554
Bristol-Myers Squibb12871
GlaxoSmithKline11066

Top states

Top states, by number of studies with a site there
StateStudies
California5,323
Florida4,472
Illinois2,493
Georgia2,366
Arizona2,253
New York2,143
Colorado2,068
Texas1,981
Massachusetts1,837
Michigan1,477

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Advanced Solid Tumor (143) Breast Cancer (135) Obesity (132) Multiple Myeloma (109) Advanced Solid Tumors (94) Colorectal Cancer (87) Overweight (84) Solid Tumor (83) Ovarian Cancer (78) Heart Failure (73) Prostate Cancer (72) Non-Small Cell Lung Cancer (71) Healthy (70) Cancer (64) Melanoma (61)
→

Browse trials by state

California (5323) Florida (4472) Illinois (2493) Georgia (2366) Arizona (2253) New York (2143) Colorado (2068) Texas (1981) Massachusetts (1837) Michigan (1477) Alabama (1309) Connecticut (1297) Maryland (1260) Ohio (1257) Indiana (1122)
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.